TD Cowen analyst Tyler Van Buren downgraded Kronos Bio Inc. (NASDAQ: KRON) from Buy to Hold.The analyst comments: "Kronos announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE